Global Digital Therapy for Obesity Market Strategic Research Report

Scope of the Report

The global Digital Therapy for Obesity market size is predicted to grow from US$ 856 million in 2025 to US$ 3,301 million in 2032; it is expected to grow at a CAGR of 21.5% from 2026 to 2032.

Digital obesity therapy refers to digital healthcare products that utilize software programs, mobile applications, artificial intelligence algorithms, digital behavioral interventions, wearable devices, telemedicine, and data analytics to provide clinically validated prevention, treatment, and long-term weight management interventions for overweight and obese individuals. Its core is not simply providing health management or dietary records, but rather changing patient behavior patterns through evidence-based medicine methods. This includes diet control, exercise management, cognitive behavioral therapy (CBT), psychological support, metabolic indicator monitoring, and personalized health guidance, thereby achieving weight loss, improved body fat percentage, reduced risk of obesity-related diseases, and long-term weight maintenance. Digital obesity therapy is typically delivered in the form of smartphone apps, web platforms, AI health assistants, digital coaches, and telemedicine platforms. It can be used alone for lifestyle interventions or in combination with GLP-1 weight loss drugs and traditional medical treatments to form a comprehensive digital obesity management system.

Digital obesity therapy, as an innovative intervention integrating software programs and evidence-based medicine, is demonstrating enormous potential to reshape the landscape of obesity management. It effectively overcomes the core bottlenecks of traditional lifestyle interventions, namely low patient adherence and insufficient personalization. By integrating technologies such as artificial intelligence, wearable devices, and remote monitoring, it achieves precise tracking of energy intake and expenditure, as well as real-time behavioral guidance. Although current research suggests that its overall weight loss effect requires higher adherence and faces challenges such as data security and long-term effectiveness, clinical evidence has shown that highly adherent users can achieve significant and clinically meaningful weight loss. With the deep integration of artificial intelligence technology and the continuous advancement of clinical validation, this type of digital therapy, which combines accessibility, personalization, and low cost, is expected to become a key complementary strategy in combating the global obesity epidemic, driving the transformation of weight management from traditional diagnosis and treatment to a continuous and precise digital care model.

This report presents a comprehensive overview of the global Digital Therapy for Obesity market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Behavior-Change Digital Therapeutics
• AI-Personalized Weight Loss Digital Therapeutics
• Medication-Assisted Digital Therapeutics for Obesity
• Others

Segment by Business Models

• B2C
• B2B
• B2B2C

Segment by players, this report covers

• Boli Care
• Click Therapeutics
• Oviva
• Liva Healthcare
• Noom
• Omada Health
• Welldoc
• Twin Health
• DarioHealth
• Sidekick Health
• Yidu Tech

Segment by Application

• Adult Obesity Management
• Childhood and Adolescent Obesity Management
• Management of Obesity with Comorbid Metabolic Diseases
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Digital Therapy for Obesity market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Adult Obesity Management, Childhood and Adolescent Obesity Management, Management of Obesity with Comorbid Metabolic Diseases evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact